immunization, Clinical & Experimental Immunology, vol.74, issue.3, pp.369-375, 2008. ,
DOI : 10.1111/j.1365-2249.2008.03705.x
Identification of a Disulfide Isomerase Protein of Leishmania major as a Putative Virulence Factor, Infection and Immunity, vol.70, issue.7, pp.3576-3585, 2002. ,
DOI : 10.1128/IAI.70.7.3576-3585.2002
Specific Cell???Mediated Cytotoxicity in Zoonotic Cutaneous Leishmaniasis, The Journal of Infectious Diseases, vol.189, issue.7, pp.1265-1273, 2004. ,
DOI : 10.1086/382031
URL : https://hal.archives-ouvertes.fr/pasteur-00875538
Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal, Tropical Medicine and International Health, vol.97, issue.1, pp.31-40, 2006. ,
DOI : 10.1046/j.1365-3156.2001.00680.x
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes, Journal of Experimental Medicine, vol.174, issue.5, pp.1209-1220, 1991. ,
DOI : 10.1084/jem.174.5.1209
Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein, Vaccine, vol.26, issue.46, pp.5888-5895, 2008. ,
DOI : 10.1016/j.vaccine.2008.05.095
IL-10 inhibits cytokine production by activated macrophages, J. Immunol, vol.147, pp.3815-3822, 1991. ,
Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice, Vaccine, vol.24, issue.29-30, pp.5708-5717, 2006. ,
DOI : 10.1016/j.vaccine.2006.04.062
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals, Vaccine, vol.26, issue.46, pp.5822-5829, 2008. ,
DOI : 10.1016/j.vaccine.2008.08.065
URL : https://hal.archives-ouvertes.fr/pasteur-00796755
LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation, Molecular Microbiology, vol.48, issue.5, pp.1169-1182, 2005. ,
DOI : 10.1111/j.1365-2958.2005.04614.x
Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.102, issue.2, pp.172-178, 2008. ,
DOI : 10.1016/j.trstmh.2007.11.004
Cutaneous leishmaniasis, The Lancet Infectious Diseases, vol.7, issue.9, pp.581-596, 2007. ,
DOI : 10.1016/S1473-3099(07)70209-8
Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: Correlation with IFN-?? and cytolytic activity by CD8+ T cells, Vaccine, vol.26, issue.35, pp.4585-4593, 2008. ,
DOI : 10.1016/j.vaccine.2008.05.091
The immunology of susceptibility and resistance to leishmania major in mice, Nature Reviews Immunology, vol.2, issue.11, pp.845-858, 2002. ,
DOI : 10.1038/nri933
Development and application of 'simple' diagnostic tools for visceral leishmaniasis, Medical Microbiology and Immunology, vol.190, issue.1-2, pp.69-71, 2001. ,
DOI : 10.1007/s004300100083